SAB 2026:  Two Strategic Days to Strengthen Cancer Research

https://crci2na.univ-nantes.fr/medias/photo/ab-2026_1790596724033

CRCI2NA welcomed its Scientific Advisory Board (SAB) for two days dedicated to the evaluation of its cancer research activities and the definition of future strategic priorities.

SAB 2026 The discussions provided an opportunity to assess the scientific quality of ongoing projects, particularly those focusing on tumor ecosystems, interactions between tumor cells and their microenvironment, and the molecular mechanisms involved in tumor initiation and progression. Strategic reflections also addressed the structuring of research programs and mid- to long-term development perspectives.

The recommendations issued by the Board represent a key lever to further strengthen the center’s scientific excellence and consolidate its national and international positioning.

CRCI2NA thanks the Board members for their valuable contributions, as well as its supervising institutions — Inserm, CNRS, Nantes Université and Université d'Angers — for their continued support of cancer research.

Updated on 28 September 2026.